Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting serotonin and dopamine receptors. Its structure supports the development of potential treatments for central nervous system disorders, including anxiety, depression, and schizophrenia. The compound's rigid bicyclic framework enhances binding selectivity, making it valuable in optimizing drug candidates for improved efficacy and reduced side effects. It is also employed in structure-activity relationship (SAR) studies to refine pharmacokinetic properties in novel psychotropic agents.